GlassScriptPhysician profile
Eric Westerlund
NPI 1811018070
$3,871.39
in general payments reported to CMS, 2019-2025
27 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $306 · 2022: $881 · 2023: $1,128 · 2024: $513 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.76 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $735.75 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $571.61 | 2021-2025 | Erleada |
| Sumitomo Pharma America, INC. | $542.49 | 2023-2025 | Gemtesa, Orgovyx |
| Globus Medical, INC. | $340.57 | 2022 | |
| Endo Pharmaceuticals INC. | $279.70 | 2021-2024 | Xiaflex, Aveed |
| Halozyme INC | $179.55 | 2023 | |
| Urovant Sciences INC | $165.90 | 2022 | |
| Boston Scientific Corporation | $150.28 | 2025 | General - Erectile Dysfunction, General - Female Sui |
| Axonics, INC. | $129.16 | 2022-2023 | Axonics |
| Endo USA, INC. | $120.82 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $119.04 | 2025 | |
| Astellas Pharma US INC | $96.46 | 2021-2025 | Myrbetriq, Xtandi |
| Tolmar, INC. | $78.12 | 2023-2024 | |
| Pfizer INC. | $54.28 | 2024-2025 | |
| Cgg Medical INC | $50.56 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $39.23 | 2021-2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $31.66 | 2025 | Provenge |
| Verity Pharmaceuticals INC. | $30.91 | 2024 | Trelstar |
| Ferring Pharmaceuticals INC. | $27.47 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $20.15 | 2023 | |
| 180 Medical, INC. | $19.53 | 2022 | |
| Abbott Laboratories | $16.76 | 2022 | |
| Hollister Incorporated | $15.16 | 2023 | Onli, Infyna Chic |
| Coloplast Corp | $14.57 | 2022 | |
| Orthofix Medical, INC. | $14.18 | 2023 | Skyhawk, Forza |
| Medtronic, INC. | $13.74 | 2023 | Interstim |
| Myriad Genetic Laboratories, INC. | $13.74 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Westerlund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.